SCHEMBL24853807

SCHEMBL24853807

C/C=C(\C)c1nc2ccccc2c2oc([Si](C)(C)C)cc12

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.42
▸ MAPK1 P28482 5/20 0.34
▸ LMNA P02545 4/20 0.34
▸ KDM4E B2RXH2 4/20 0.34
▸ SMN1; SMN2 Q16637 5/20 0.34
▸ HTT P42858 5/20 0.34
▸ POLB P06746 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ HPGD P15428 1/20 0.33
▸ MAPT P10636 3/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ ELANE P08246 4/20 0.33
▸ TSHR P16473 2/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24853596 0.89 ALDH1A1 (0.36) ALDH1A1LMNAKDM4ESMN1; SMN2HPGD
SCHEMBL24853587 0.75 ALDH1A1 (0.36) ALDH1A1LMNAKDM4ESMN1; SMN2HTT
SCHEMBL24853579 0.71 TP53 (0.34) LMNASMN1; SMN2HPGDMAPTMEN1
SCHEMBL22431673 0.70 CSNK2A1 (0.38) ALDH1A1KDM4ESMN1; SMN2HTTNPSR1
SCHEMBL24854100 0.70 GPR3 (0.36) ALDH1A1MAPK1KDM4ESMN1; SMN2POLB
SCHEMBL24853605 0.67 ALDH1A1 (0.40) ALDH1A1LMNAKDM4ESMN1; SMN2HTT
SCHEMBL24853805 0.66 ELANE (0.40) ALDH1A1KDM4ESMN1; SMN2HPGDMEN1
SCHEMBL24853790 0.64 GPR3 (0.36) ALDH1A1KDM4ESMN1; SMN2HTTPOLB
SCHEMBL24853588 0.61 ALDH1A1 (0.40) ALDH1A1LMNAKDM4ESMN1; SMN2HTT
SCHEMBL18576588 0.59 CYP2A6 (0.52) ALDH1A1MAPK1LMNASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002427-A1 ORGANOMETALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-01-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002427-A1 ORGANOMETALLIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME NONO, BMI1, LIG1 ALDH1A1 745/4885MAPK1 2114/4885LMNA 2229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback